PMN
ProMIS Neurosciences Inc.
9.40$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.9% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 97.3% | 100.0% | |
| 94.4% | – | 70.4% | 70.4% | 87.9% | 70.3% | 61.3% | 47.4% | 71.8% | 66.6% | 94.7% | 94.2% | |
| 94.7% | – | 71.3% | 72.7% | 88.0% | 70.5% | 61.5% | 47.8% | 71.9% | 67.0% | 94.7% | 94.3% | |
| 0.7% | – | 2.2% | 5.1% | 2.6% | 0.4% | 0.4% | 0.3% | 0.4% | 0.4% | 0.4% | – | |
| -0.7% | – | -2.2% | 0.0% | – | – | – | – | – | – | – | – | |
| 0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 62.2% | – | 97.8% | 261.5% | 70.3% | 12.8% | 30.6% | 104.0% | 57.2% | 113.7% | 9.9% | 12.9% | |
| 55.1% | – | 74.6% | 225.0% | 10.8% | 11.7% | 29.7% | 103.3% | 56.9% | 113.4% | 9.8% | 12.7% | |
| 47.1% | – | 39.6% | 143.0% | 6.4% | 9.2% | 8.8% | 29.2% | 19.6% | 27.7% | 2.5% | 3.2% | |
| 37.8% | – | 2.2% | -161.5% | 29.7% | 87.2% | 69.4% | -4.0% | 42.8% | -13.7% | 90.1% | 87.1% | |
| -502.8% | – | -2,736.6% | -7,074.7% | -369.0% | -479.5% | -718.4% | -1,137.3% | -558.0% | -1,420.2% | -205.7% | -265.2% | |
| 2.0% | – | 22.0% | 56.1% | 4.9% | 7.4% | 10.2% | 14.7% | 6.5% | 19.1% | 9.7% | 16.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.